Cargando…

Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence

BACKGROUND: Osteosarcoma is the most common malignant primary bone tumour in young adult treated by neo adjuvant chemotherapy, surgical tumor removal and adjuvant multidrug chemotherapy. For correction of soft tissue defect consecutive to surgery and/or tumor treatment, autologous fat graft has been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perrot, Pierre, Rousseau, Julie, Bouffaut, Anne-Laure, Rédini, Françoise, Cassagnau, Elisabeth, Deschaseaux, Frédéric, Heymann, Marie-Françoise, Heymann, Dominique, Duteille, Franck, Trichet, Valérie, Gouin, François
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882323/ https://www.ncbi.nlm.nih.gov/pubmed/20544017 http://dx.doi.org/10.1371/journal.pone.0010999

Ejemplares similares

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma
por: Ando, Kosei, et al.
Publicado: (2013)

Molecular Alterations Associated with Osteosarcoma Development
por: Ando, Kosei, et al.
Publicado: (2012)

The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem
por: Corre, Isabelle, et al.
Publicado: (2020)

Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
por: Picarda, Gaëlle, et al.
Publicado: (2013)

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases
por: Lamora, Audrey, et al.
Publicado: (2015)

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma
por: Redini, Françoise, et al.
Publicado: (2015)

Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma
por: Dumars, Clotilde, et al.
Publicado: (2016)

Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy
por: Chalopin, Antoine, et al.
Publicado: (2018)

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models
por: Gobin, Bérengère, et al.
Publicado: (2014)

Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells
por: Ory, B, et al.
Publicado: (2008)

Advances in Osteosarcoma
por: Panez-Toro, Isidora, et al.
Publicado: (2023)

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma
por: Lamoureux, Francois, et al.
Publicado: (2014)

Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma
por: Théoleyre, S, et al.
Publicado: (2005)

(99m)Tc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model
por: Miot-Noirault, Elisabeth, et al.
Publicado: (2013)

Biology of Bone Sarcomas and New Therapeutic Developments
por: Brown, Hannah K., et al.
Publicado: (2017)

ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells
por: Danieau, Geoffroy, et al.
Publicado: (2021)

Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment
por: Verrecchia, Franck, et al.
Publicado: (2018)

Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma
por: Jubelin, Camille, et al.
Publicado: (2022)

Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing’s sarcoma via inhibition of cell migration
por: Odri, Guillaume, et al.
Publicado: (2014)

Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients
por: Heymann, Clément J.F., et al.
Publicado: (2022)

Jaw osteosarcoma models in mice: first description
por: Bertin, Hélios, et al.
Publicado: (2019)

LIM Kinases in Osteosarcoma Development
por: Brion, Régis, et al.
Publicado: (2021)

Pericyte-Like Progenitors Show High Immaturity and Engraftment Potential as Compared with Mesenchymal Stem Cells
por: Bouacida, Amina, et al.
Publicado: (2012)

The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung Metastases
por: Navet, Benjamin, et al.
Publicado: (2018)

Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma
por: Muñoz-Garcia, Javier, et al.
Publicado: (2022)

Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection status
por: Avril, Pierre, et al.
Publicado: (2015)

The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets
por: David, E., et al.
Publicado: (2011)

RANK–RANKL signalling in cancer
por: Renema, Nathalie, et al.
Publicado: (2016)

A“Proteoglycan Targeting Strategy” for the Scintigraphic Imaging and Monitoring of the Swarm Rat Chondrosarcoma Orthotopic Model
por: Peyrode, Caroline, et al.
Publicado: (2011)

Technical report: liquid overlay technique allows the generation of homogeneous osteosarcoma, glioblastoma, lung and prostate adenocarcinoma spheroids that can be used for drug cytotoxicity measurements
por: Jubelin, Camille, et al.
Publicado: (2023)

A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis
por: Le Goff, Benoit, et al.
Publicado: (2009)

TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
por: Lamora, Audrey, et al.
Publicado: (2016)

Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
por: Tellez-Gabriel, Marta, et al.
Publicado: (2019)

Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers
por: Ségaliny, Aude I., et al.
Publicado: (2015)

Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1
por: Jacques, Camille, et al.
Publicado: (2016)

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016)

The Challenges of Detecting Circulating Tumor Cells in Sarcoma
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016)

Maternal RANKL Reduces the Osteopetrotic Phenotype of Null Mutant Mouse Pups
por: Navet, Benjamin, et al.
Publicado: (2018)

Epinephrine Infiltration of Adipose Tissue Impacts MCF7 Breast Cancer Cells and Total Lipid Content
por: Avril, Pierre, et al.
Publicado: (2019)

Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine
por: Tellez-Gabriel, Marta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d7lua7h3ealjf3rvdmrsnenop3